Features | |
---|---|
Mean age at onset (yr) | 74.5 (range, 54–88) |
Men | 7 of 10 (70%) |
Upper limb affected | 8 of 10 (80%) |
Mean interval between rash and weakness (days) | 18 |
Neuralgia 1 mo after rash | 10 of 10 (100%) |
Neuralgia 3 mo after rash | 7 of 10 (70%) |
Corticosteroid treatment | 6 of 10 (60%) |
Diabetes mellitus | 2 of 10 (20%) |
Immunosuppression | 1 of 10 (10%) |